October 24, 2006 Advisory Committee on Research on Women’s Health. 1 Summary Report of NIH Inclusion Data – FY2005 Carlos E. Caban, Ph.D., M.P.H. Office.

Slides:



Advertisements
Similar presentations
1 Sex/Gender and Minority Inclusion in NIH Clinical Research What Investigators Need to Know!
Advertisements

CBER Isolagen Therapy (IT) BLA FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.
Hawaii’s Uninsured Population: Estimates from the Behavioral Risk Factor Surveillance System, 2000 and 2001 Lawrence Nitz Gerard Russo Sang-Hyop Lee Timothy.
Ralph S. Caraballo, PhD, MPH Valerie J. Rock, MPH Epidemiology Branch Chief Office on Smoking and Health CDC TM 2nd Conference on Menthol Cigarettes October.
NIH Research Funding Trends: FY Produced by Howard H. Garrison, Ph.D. and Kimberly McGuire FASEB Office of Public Affairs Data Sources: NIH Office.
Training and Career Development Analyses: NICHD Diversity Supplements and F31 Pre-doctoral Fellowships Jennifer Guimond, PhD and Sarah Glavin, PhD Science.
Dealing With A Future Which Is in Perpetual Construction---Washington State Provisional Projection by Age, Sex And Race/Ethnicity: Office of.
How do Morgan & Scott County Children Enter the Child Welfare System? Morgan and Scott Counties Indicated reports FY 2010 SourceNumber Percent of total.
STD Surveillance 2001 Adapted from CDC by Jill Gallin, CPNP Assistant Professor of Clinical Nursing.
Individual Bioequivalence Lawrence J. Lesko, Ph.D. Director Office of Clinical Pharmacology and Biopharmaceutics Advisory Committee for Pharmaceutical.
Vaccines and Related Biological Products Advisory Committee Presentation on Sanofi Pasteur’s H5N1 Vaccine Andrea N. James, M.D. Senior Medical Officer.
ILLNESSES, INJURIES, AND HOSPITALIZATIONS AMONG INNER-CITY MINORITY INFANTS IN CHICAGO.
NIH Research Funding Trends: FY Produced by
Assessing Minority Participation in Clinical Trials: Setting Attainable Goals The Minority and Women Clinical Trials Recruitment Program Department of.
National Projections Program, 2005 Population Projections Branch Population Division U.S. Census Bureau.
Data provided by the Division of Statistical Analysis & Reporting (DSAR)/OPAC/OER Contact: Best Practices: Leveraging Existing Data.
1 Sex/Gender and Minority Inclusion in NIH Clinical Research What Investigators Need to Know! Presenter: Miriam F. Kelty, PhD, National Institute on Aging,
NIH LOAN REPAYMENT PROGRAM EVALUATION Milton J. Hernández, Ph.D. Director Division of Loan Repayment OEP, OER, OD National Institutes of Health Bethesda,
1 How Complete is California’s HIV Status Determination Among 2008 TB Cases? Darryl Kong, MPH TB Control Branch California Department of Public Health.
Aidsnet.org Miami-Dade County HIV/AIDS Epidemiological Data October 25, 2011 Data provided by the Florida Department of Health HIV/AIDS Surveillance Program.
Slide 1 Community Networks to Reduce Cancer Health Disparities Pre-Application Conference May 26, 2004 Bethesda, MD Kenneth C. Chu, PhD Chief, Disparities.
Are Women’s Health Concerns Prioritized at the NIH and the FDA? Nicole C. Quon, Ph.D. Assistant Professor Indiana University.
Comparative Analyses of Three Measures of Concordance between Current and Longest Held Jobs Orlando Gómez-Marín MSc PhD, Lora E. Fleming MD PhD, William.
DODAC and DSaRM Advisory Committee August 1, 2007 Pregnancy Registry and Root Cause Analysis Cynthia Kornegay, Ph.D. Division of Drug Risk Evaluation Office.
Inclusion of Women in Clinical Trials & Drug Development Regulatory Perspective Ameeta Parekh, Ph.D. R&D Director Office of Women’s Health Food & Drug.
Guidelines for Clinical Trial Registration.. Background. In 2005 the International Committee of Medical Journal Editors (ICMJE) announced that in order.
The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.
State of Alaska Section of Epidemiology HIV Epidemiologic Profile Published: March 27,
1 AIRI STATISTICS: TRENDS IN NIH EXTRAMURAL FUNDING Presented at the Association of Independent Research Institutes (AIRI) 50 th Annual Meeting October.
Lots of funny looking graphs. Age distribution Dependency ratio: number of people who are too young/old to work compared to the number of productive.
1 AIRI STATISTICS: TRENDS IN NIH AWARDS Presented at Association of Independent Research Institutes 49 th Annual Meeting September 29, 2010 Washington,
BREAST CANCER BY STAGE OF DISEASE AT DIAGNOSIS, CENTRAL OKLAHOMA Arthur Owora, MPH; Aaron Wendelboe, PhD; David Thompson, PhD; Janis Campbell, PhD The.
Training Program Evaluation: Creating a Composite Indicator to Measure Career Outcomes National Institutes of Health / National Cancer Institute & Thomson.
Jun Li, MD MPH Epidemic Intelligence Service Officer
Participants 18year old+
Clinicaltrials.gov Update
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Download date: Sept 2011.
Mongolia Last updated: April 2016.
ClinicalTrials.gov: An introduction
Pakistan Last updated: July 2015.
12 Gender, Race, and Ethnicity in the Labor Market.
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
The Dentist Workforce in North Carolina
A study of high risk African American women, 15 to 21 years of age
NIH Research Funding Trends: FY Produced by
NIH Research Funding Trends: FY
NIH Research Funding Trends: FY Produced by
JH Trial Innovation Unit (TIU)
NIH Research Funding Trends: FY
FY17 Research Management Annual Financial Update
Snapshot of the Clinical Trials Enterprise as revealed by ClinicalTrials.gov Content downloaded: September 2012.
New NIH Human Subjects & Clinical Trials Information
Physics Enrolments: Past, Present and Future
Burden of Diabetes in Connecticut: An Overview
NIH Research Funding Trends: FY
Burden of Diabetes in Connecticut: An Overview
Getting U.S. Basic Research Back on Track
National Institute of Health: Updates from NIH Regional Seminar 2017
NIH Research Funding Trends: FY
Sexually Transmitted Infections (STIs) in Ireland, 2016
Understanding health behavior and perceptions
Surveillance of Tuberculosis
Who are the Subjects? Intro to Sampling
Diversity in Willamalane’s Workplace
Time use survey In Serbia
2008 National STD Prevention Conference Chicago, Illinois
Did not have a usual source of care Went without care because of cost
Figure 2. Infant mortality rates by sex of child and race and ethnicity of mother: United States, 2008 * * * * * * * * * Significantly different 1/ Includes.
A randomized, controlled trial of a patient-centered disclosure counseling intervention for Kenyan children living with HIV. Rachel C. Vreeman, MD, MS;
Risk Ratio A risk ratio, or relative risk, compares the risk of some health-related event such as disease or death in two groups. The two groups are typically.
Presentation transcript:

October 24, 2006 Advisory Committee on Research on Women’s Health. 1 Summary Report of NIH Inclusion Data – FY2005 Carlos E. Caban, Ph.D., M.P.H. Office of Extramural Research, OD NIH October 24, 2006

Advisory Committee on Research on Women’s Health. 2 Overview of the Report Data Executive Summary Tables Total NIH Clinical Research Reported in FY2005 is summarized in revised tables Trend Data is provided for up to 11 years Comparisons available include: –All Clinical Research versus NIH Defined Phase III Trials –Female versus Male participation –Extramural versus Intramural Studies –Domestic versus Foreign Studies –Summary of Minority Data –Trends for up to 11 years Appendix Tables Appendix H: Race and Ethnicity Categories Included in Summary Minority Data

October 24, 2006 Advisory Committee on Research on Women’s Health. 3 NIH Clinical Research NIH Clinical research studies are determined in accordance with the definition of clinical research to include, for example, non- intervention clinical research, clinical trials, epidemiologic studies, behavioral studies, and database studies. Data on inclusion is tabulated by looking at human subject populations in NIH-defined Phase III clinical trials and other human subject research studies. "Total All Clinical Studies" includes NIH Defined Phase III Clinical Trials.

October 24, 2006 Advisory Committee on Research on Women’s Health. 4 A. Executive Summary Tables: NIH Wide Clinical Research Reported in FY2005 Tables Summary: NIH Clinical Research – Overview – Reported in FY Summary of NIH Clinical Research 2. Summary of Sex-Specific Protocols, Summary: NIH Defined Phase III Research – Overview- FY Summary of NIH Phase III Clinical Research 4. Summary of NIH Phase III Sex-Specific Protocols Summary: Eleven Year Trend Reports: FY Summary: Eleven Year Trend Report 6. Eleven Year Minority Trend Report 7. Eleven Year Minority Trend Report...Phase III 8. Domestic Protocols: Domestic Protocols, NIH Phase III: Foreign Protocols: Foreign Protocols, Phase III:

October 24, 2006 Advisory Committee on Research on Women’s Health. 5

October 24, 2006 Advisory Committee on Research on Women’s Health. 6 Brief Data Summary Brief Presentations: Summary of NIH Clinical Research Reported in FY2005 – Table 1 Presentation of Trend Data – –Female and Male Enrollment –Protocols and Enrollment –Domestic and Foreign –Minority Inclusion

October 24, 2006 Advisory Committee on Research on Women’s Health. 7 Table 1. Summary of NIH Clinical Research Reported in FY2005 : Total Number of Protocols & Enrollment By Sex & Domestic vs. Foreign Protocols 1A. PROTOCOLS REPORTED 1A. PROTOCOLS REPORTED Total All Clinical Studies*Domestic%Foreign% Protocols with Enrollment10,2339, %3713.6% %69.2%69.4% 62.7% Protocols with zero enrollment. Enrollment data has not yet been submitted4,5654, %2214.8% 30.8%30.6% 37.3% Total Number of Protocols14,79814, %5924.0% %100.0% 1. Total number of protocols reported in the NIH database in FY2005 was 14,798; of these, 10,233(69.2%) reported subject enrollment. 2. Subsequent Tables reporting "Enrollment Reported" are based on the 10,233 protocols reporting subject enrollment, or a defined subset. 3. Protocols with zero enrollment (data not yet submitted) are not included in subsequent tables reporting "Enrollment reported." 4. Domestic protocols made up the vast majority of protocols (14,206; 96.0%); of these, 9,862 (69.4%) reported domestic subject enrollment.

October 24, 2006 Advisory Committee on Research on Women’s Health. 8 1B. ENROLLMENT REPORTED Total All Clinical Studies*Domestic%Foreign% Females Enrolled9,503,9227,887, %1,616, % %60.4%62.3% 53.0% Males Enrolled5,941,9074,515, %1,426, % %37.8%35.6% 46.7% Sex of Subjects is Unknown276,923267, %9,5163.4% %1.8%2.1% 0.3% Total Subjects Enrolled15,722,75212,669, %3,052, % %100.0% 1. The total "Enrollment Reported" in the NIH database in FY2005 was 15, 722, 752 subjects in 10,233 protocols with enrollment. 2. Females made up 60.4% (9.5M) of the total subjects enrolled, while Males made up 37.8%(5.9M), with 1.8% (.277M) unknown. 4. The total Domestic Enrollment reported was 12,669,858 (80.6%). 5. Females made up 62.3%(7.9M) of the domestic subjects enrolled, while Males made up 35.6%(4.5M), with 2.1%(.267M) unknown.

October 24, 2006 Advisory Committee on Research on Women’s Health. 9 1C. MINORITY ENROLLMENT REPORTED 1. Minorities made up 39.7% of total subjects enrolled. 2. Minorities made up 27.4%(3.47M) of the Domestic Enrollment and 90.9% of the Foreign Enrollment. 3. The Total Minority Enrollment was made up of 55.5% Domestic and 44.5% Foreign enrollment. The small percentage of foreign protocols (4%) account for a significant proportion (44.5%) of the Total Minority Enrollment. Total All Clinical Studies*Domestic%Foreign% 1B. Total Subjects Enrolled15,722,75212,669, %3,052, % 1C. MINORITY ENROLLMENT REPORTED Total All Clinical Studies*Domestic%Foreign% Minority Total**6,245,4363,468, %2,776, % 39.7%27.4% 90.9%

October 24, 2006 Advisory Committee on Research on Women’s Health There was a 3.2 fold increase in protocols, from 3,188 protocols to 10,233 protocols. 2. There was a 15.4 fold increase in enrollment, from approximately 1.0M to 15.7 M. 3. There was a 16.7 fold increase in minority enrollment, from 0.37M to 6.2 M. 4. Domestic and Foreign data (FY ), and showed 1.2 fold increase in domestic enrollment (from 10.2M to 12.7M) and a 3.2 fold increase in foreign enrollment (from 0.95M to 3.0M). 5A. Eleven Year Increases in Protocols and Enrollment Data FY Reported Relative Increase, 2005 / 1995 Total Protocols with enrollment3,188 10, Total Enrollment1,021,493 15,722, Total Minorities374,433 6,245, % of Minority36.7% 39.7%1.1 FY Reported Relative Increase, 2005 / 2002 Total DOMESTIC Enrollment data10,192,401 12,669, Total FOREIGN Enrollment 946,083 3,052,8943.2

October 24, 2006 Advisory Committee on Research on Women’s Health. 11 5B. Eleven Year Summary of Total Protocols Reported in FY FY ReportedFY Funded Number of Protocols with Enrollment data (Old + New Forms): Number of DOMESTIC Protocols with Enrollment data Number of FOREIGN Protocols with Enrollment data Percent Domestic Protocols Protocol Form* ,188 Old , , , , , , ,9458, % Old + New ,2169, % ,1259, % ,2339, %

October 24, 2006 Advisory Committee on Research on Women’s Health. 12 Eleven Year Trends for Protocol and Enrollment Data: B.Eleven Year Summary of Total Protocols Reported in FY Total Protocols by Year Reported Note: The arrow in the graph indicates that the old Form was used until 2001 reports, and both the OLD and NEW FORMS were used for reports.

October 24, 2006 Advisory Committee on Research on Women’s Health. 13 5C. Comparison of Domestic and Foreign Enrollment Reported in FY FY ReportedFY Funded Total Enrollment data (Old+New Forms): Total DOMESTIC Enrollment data Percent DOMESTIC Enrollment Total FOREIGN Enrollment Percent FOREIGN Enrollment ,138,48410,192, %946,0838.5% ,772,25411,911, %2,860, % ,923,92014,359, %4,564, % ,722,75212,669, %3,052, %

October 24, 2006 Advisory Committee on Research on Women’s Health. 14 5C. Comparison of Domestic and Foreign Enrollment Reported in FY Percent Comparison of Domestic and Foreign Enrollment

October 24, 2006 Advisory Committee on Research on Women’s Health. 15 6A.Sex/Gender Enrollment by Year Reported

October 24, 2006 Advisory Committee on Research on Women’s Health. 16 6F. Comparison of Domestic and Foreign Minority Participation for FY FY ReportedFY Funded FOREIGN Minority Enrollment Foreign Total Enrollment DOMESTIC Minority Enrollment Domestic Total Enrollment ,461946,0832,754,82010,149, %100.0%27.1%100.0% ,452,3292,860,8972,935,36311,911, %100.0%24.6%100.0% ,147,2554,564,1273,464,35614,359, %100.0%24.1%100.0% ,776,5653,052,8943,468,86412,669, %100.0%27.4%100.0%

October 24, 2006 Advisory Committee on Research on Women’s Health. 17 Number of Minority Participants for FY Comparison of % Domestic Minority Enrollment to Total Domestic Enrollment

October 24, 2006 Advisory Committee on Research on Women’s Health. 18 General Summary The number of clinical studies and total and minority enrollment have increased significantly over 11 years More Females have been reported than males, although the F/M ratio is relatively constant The vast majority are domestic studies Domestic minority enrollment has been ~25% of total domestic enrollment